Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs AVAV✓SelectedUSD · AVAVMRNA vs AVAV performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs AVAV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
AVAV return
-30.8%
Excess return
+177.8%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioAVAVExcessAlpha
1D-2.2%-9.5%+7.3%-0.7%
7D-12.7%-26.1%+13.4%-8.5%
30D-20.7%-26.1%+5.5%-17.1%
3M+46.3%-45.7%+91.9%+59.5%
6M+305.2%-47.0%+352.3%+341.7%
YTD+561.2%-64.1%+625.4%+640.2%
1Y+772.1%-68.3%+840.4%+887.9%
3Y+147.0%-32.4%+179.3%+152.1%
All+147.0%-30.8%+177.8%+152.1%

Cumulative growth

Daily Returns

Daily percentage return beside AVAV.

Daily Out/Under-Performance

Portfolio return minus AVAV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling